IBC's international Conference on Novel Therapeutic Proteins for Oncology (drug discovery and development)

R J Kreitman1

  • 1Laboratory of Molecular Biology, Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

New therapeutic proteins offer hope for treating incurable cancers. Research presented at a recent conference highlights novel agents and strategies for targeting tumor cells, addressing the urgent need for advanced cancer therapies.

Area of Science:

  • Oncology
  • Biotechnology
  • Cancer Research

Background:

  • An estimated 564,800 American cancer deaths were projected for 1998.
  • While earlier detection and healthier lifestyles show some impact, new treatments are crucial for incurable cancers.

Purpose of the Study:

  • To review novel therapeutic agents and strategies for targeting tumor cells.
  • To highlight advancements discussed at the International Conference on Novel Therapeutic Proteins for Oncology.

Main Methods:

  • Review of presented data and strategies from a conference.
  • Discussion of new agents and therapeutic approaches for cancer treatment.

Main Results:

  • A wide range of new agents and strategies for targeting tumor cells were presented.
  • The review covers diverse therapeutic proteins and innovative treatment modalities.

Conclusions:

  • Novel therapeutic proteins and targeted strategies represent a promising frontier in oncology.
  • Continued research and development are essential to combat incurable cancers effectively.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...